Fundraising Fox

Lauxera Capital Partners

Growth equity

Paris · Growth–Late Stage · 16 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Lauxera invests in healthtech businesses that have reached early profitability, aiming to catalyze inflections in growth through new innovation, commercial investment, business development, and stronger talent. The firm partners with founders and world-class managers, contributing both capital and operational expertise to improve the efficiency of the healthtech system, save lives, and reduce costs. Its team combines entrepreneurial company builders with experienced investors who have guided healthtech companies across all growth stages. Lauxera operates from offices in Europe and the United States and targets investment tickets ranging from roughly 20 to 100 million euros.

Invests inBiotechDigital HealthHealthtechMedical DevicesEuropeFranceGlobalLatin AmericaNorth AmericaParisUnited States

Source: firm website, verified Aug 11, 2026.

Stage
Growth–Late Stage
Check
$22M – $110M
HQ
Paris, FR
Leads rounds
Leads
Instruments
Equity
AUM
$880M
Tracked investments
15

Team · 16 people

from the firm's website

What they invest in

from 3 of 15 portfolio companies

Healthtech ×2Medical Devices ×2Biotech ×1Digital Health ×1FemTech ×1

HQs:United States×1

Investments · 15 tracked

founders shown can be your intro path
Acandis

German neurovascular device company; a minority investment from Lauxera Growth II.

Antaros Medical

Swedish advanced imaging CRO; a majority investment from Lauxera Growth II.

BioLamina
Caresyntaxcaresyntax.comNov 2019

HealthtechBoston, US

Filip Pintelon(Director)Werner Zoellner(Director)Paul Summerside(Director)Bjoern von Siemens(Executive Officer, Director)Timothy Lantz(Executive Officer)Dennis Kogan(Executive Officer, Director)

Lifenlifen.fr

Purple fund portfolio company.

LUMICKS
Matrix One
Natural Cyclesnaturalcycles.com

Natural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning.

Digital HealthFemTechMedical Devices

OrganOxorganox.comin

OrganOx develops organ preservation and transplantation technology used by research institutions to keep and treat organs, aimed at supporting transplantation and reducing the future need for transplants.

BiotechHealthtechMedical Devices

Ospi
Quantiumportalquantiumportal.com
Reapplix
Synovo Group
Veranex
Verdot

Frequently asked questions

What stage does Lauxera Capital Partners invest at?
Lauxera Capital Partners invests at the Growth, Late Stage stages.
What is Lauxera Capital Partners's typical check size?
Lauxera Capital Partners typically writes checks of $22M – $110M.
What sectors does Lauxera Capital Partners focus on?
Lauxera Capital Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Lauxera Capital Partners located?
Lauxera Capital Partners is headquartered in Paris, FR.
Does Lauxera Capital Partners lead rounds?
Yes, Lauxera Capital Partners leads investment rounds.

Media · Podcasts & interviews

featuring the team

SMART BOURSE - Marchés à thème(s) : Pierre Moustial (Lauxera Capital Partners)

B SMART · Pierre Moustial

Pierre Moustial (Lauxera Capital Partners) & Martial Descoutures (Oddo BHF): Le journal des Biotechs

Boursorama · Pierre Moustial

BE SMART - L'interview de Pierre Moustial (Lauxera Capital Partners) par Stéphane Soumier

B SMART · Pierre Moustial

Images

Lauxera Capital Partners photoLauxera Capital Partners photoLauxera Capital Partners photoLauxera Capital Partners photoLauxera Capital Partners photoLauxera Capital Partners photo

Similar investors

Featured in lists